Pfizer is an American multinational pharmaceutical and biotechnology corporation that develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. In this article, we discuss the top Pfizer Competitors and Alternatives.
With a history that dates back to 1849, Pfizer has established itself as a trusted name in the pharmaceutical industry.
Pfizer is known for its commitment to innovation and cutting-edge research and development. The company invests heavily in research and development to discover new and effective treatments for patients with various health issues. Pfizer has a diverse product portfolio spans multiple therapeutic areas, including cardiovascular medicine, oncology, immunology, and rare diseases.
- Product Type: Pharmaceutical drugs and vaccines
- Industry: Pharmaceutical and biotechnology
- Founded Date: 1849
- Founders: Charles Pfizer and Charles F. Erhart
- Headquarters: The Spiral, New York City, United States
- Area Served: Worldwide
- Current CEO: Albert Bourla
Table of Contents
The top Pfizer competitors are
1. Johnson & Johnson
- Product Type: Consumer goods, pharmaceuticals, medical devices
- Industry: Healthcare
- Founded Date: 1886
- Founders: Robert Wood Johnson I, James Wood Johnson, Edward Mead Johnson
- Headquarters: New Brunswick, New Jersey, United States
- Area Served: Worldwide
- Current CEO: Alex Gorsky
- Market capitalization: $443.5 billion (October 2023)
Johnson & Johnson is a multinational company dedicated to developing medical devices, pharmaceuticals, and consumer packaged goods. Rather than other companies just focusing on pharmaceuticals, Johnson & Johnson differentiates itself by providing patients with a broad scope of healthcare products. The company’s consistent innovation and product diversification have helped it to compete directly with Pfizer in many healthcare business segments.
2. Roche Holding AG
- Product Type: Pharmaceuticals, diagnostics
- Industry: Healthcare
- Founded Date: 1896
- Founders: Fritz Hoffmann-La Roche
- Headquarters: Basel, Switzerland
- Area Served: Worldwide
- Current CEO: Severin Schwan
- Market capitalization: CHF 316.5 billion (October 2023)
Roche Holding AG is a Swiss multinational healthcare company operating worldwide under two divisions: Pharmaceuticals and Diagnostics. Roche’s extensive portfolio includes treatments for a wide range of diseases, including cancer, HIV/AIDS, hepatitis, and rheumatoid arthritis. Roche’s innovative approach to pharmaceuticals and commitment to research and development make it a significant competitor in the industry.
3. Merck & Co.
- Product Type: Pharmaceuticals, vaccines, animal health
- Industry: Healthcare
- Founded Date: 1891
- Founders: George Merck
- Headquarters: Kenilworth, New Jersey, United States
- Area Served: Worldwide
- Current CEO: Robert M. Davis
- Market capitalization: $232.5 billion (October 2023)
Merck & Co. is a global healthcare company working to create innovative health solutions. The company is particularly noted for its work in developing medicines and vaccines for many of the world’s most challenging diseases. This commitment to breakthrough research has positioned Merck & Co. as a competitor to Pfizer, especially in areas such as oncology and diabetes.
4. Novartis AG
- Product Type: Pharmaceuticals, generics, eye care
- Industry: Healthcare
- Founded Date: 1996
- Founders: Merger of Ciba-Geigy and Sandoz
- Headquarters: Basel, Switzerland
- Area Served: Worldwide
- Current CEO: Vasant Narasimhan
- Market capitalization: CHF 236.5 billion (October 2023)
Novartis AG is a Swiss pharmaceutical company that researches, develops, manufactures, and markets a wide range of healthcare products. Notable for its commitment to innovative and high-quality pharmaceuticals, Novartis AG competes directly with Pfizer in numerous therapeutic areas.
5. GlaxoSmithKline plc
- Product Type: Pharmaceuticals, vaccines, consumer healthcare
- Industry: Healthcare
- Founded Date: 2000
- Founders: Merger of Glaxo Wellcome and SmithKline Beecham
- Headquarters: Brentford, United Kingdom
- Area Served: Worldwide
- Current CEO: Emma Walmsley
- Market capitalization: £77.2 billion (October 2023)
GlaxoSmithKline plc is a British multinational pharmaceutical company. It researches, develops, and manufactures innovative pharmaceutical medicines, vaccines, and consumer healthcare products. Known for its significant contributions to respiratory and HIV treatments, GlaxoSmithKline stands as a noteworthy competitor in the pharmaceutical and animal health products industry.
6. AstraZeneca plc
- Product Type: Pharmaceuticals, biopharmaceuticals
- Industry: Healthcare
- Founded Date: 1999
- Founders: Merger of Astra AB and Zeneca Group plc
- Headquarters: Cambridge, United Kingdom
- Area Served: Worldwide
- Current CEO: Pascal Soriot
- Market capitalization: £98.5 billion (October 2023)
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company. It focuses on discovering, developing, and commercializing prescription pharmaceuticals, primarily for treating diseases in three therapy areas – Oncology, Cardiovascular & Metabolic Diseases, and Respiratory. Their ground-breaking science and approach to medicine make them a direct competitor to Pfizer.
7. Sanofi S.A.
- Product Type: Pharmaceuticals, vaccines, consumer healthcare
- Industry: Healthcare
- Founded Date: 1973
- Founders: Merger of Elf Aquitaine and TotalFina
- Headquarters: Paris, France
- Area Served: Worldwide
- Current CEO: Paul Hudson
- Market capitalization: €107.5 billion (October 2023)
Sanofi S.A. is a French multinational pharmaceutical company engaged in therapeutic solutions research, development, manufacture, and marketing. With effective medicines in its wide-ranging portfolio, including vaccines and over-the-counter (OTC) medication, Sanofi maintains a significant and robust presence everywhere in the healthcare industry.
8. AbbVie Inc.
- Product Type: Pharmaceuticals, biopharmaceuticals
- Industry: Healthcare
- Founded Date: 2013
- Founders: Spin-off from Abbott Laboratories
- Headquarters: North Chicago, Illinois, United States
- Area Served: Worldwide
- Current CEO: Richard A. Gonzalez
- Market capitalization: $200.3 billion (October 2023)
AbbVie Inc. is a global biopharmaceutical company committed to creating innovative, advanced therapies for some of the world’s most complex and critical conditions. Its comprehensive portfolio of medicines, which includes a significant focus on immunology and oncology, pits AbbVie as a strong competitor in the industry.
9. Bristol-Myers Squibb Company
- Product Type: Pharmaceuticals, biopharmaceuticals
- Industry: Healthcare
- Founded Date: 1858
- Founders: Edward Robinson Squibb
- Headquarters: New York City, New York, United States
- Area Served: Worldwide
- Current CEO: Giovanni Caforio
- Market capitalization: $142.6 billion (October 2023)
Bristol-Myers Squibb Company is an American pharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. Their focus on bio-pharmaceuticals and diverse product portfolio allows them to compete with competitors of Pfizer in various business segments.
10. Gilead Sciences, Inc.
- Product Type: Pharmaceuticals, biopharmaceuticals
- Industry: Healthcare
- Founded Date: 1987
- Founders: Michael L. Riordan
- Headquarters: Foster City, California, United States
- Area Served: Worldwide
- Current CEO: Daniel O’Day
- Market capitalization: $85.2 billion (October 2023)
Gilead Sciences, Inc. is an American biopharmaceutical company researching, developing, and commercializing drugs. The company’s portfolio mainly focuses on antiviral medications for HIV, hepatitis B, hepatitis C, and influenza. Gilead’s strengths lie in its evolutionary antiviral therapies, setting it as a critical player in the field.
11. Amgen Inc.
- Product Type: Biotechnology, biopharmaceuticals
- Industry: Healthcare
- Founded Date: 1980
- Founders: George B. Rathmann
- Headquarters: Thousand Oaks, California, United States
- Area Served: Worldwide
- Current CEO: Robert A. Bradway
- Market capitalization: $138.9 billion (October 2023)
Amgen Inc. is a biotechnology company situated in the United States. They are pioneers of recombinant DNA technology, employing it to produce human therapeutics. The company focuses on areas where existing treatments are limited, including oncology, nephrology, and cardiology. This aids them in taking a lead position and directly competing with firms like Pfizer.
12. Eli Lilly and Company
- Product Type: Pharmaceuticals, biopharmaceuticals
- Industry: Healthcare
- Founded Date: 1876
- Founders: Eli Lilly
- Headquarters: Indianapolis, Indiana, United States
- Area Served: Worldwide
- Current CEO: David A. Ricks
- Market capitalization: $202.4 billion (October 2023)
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to create medicines that improve lives worldwide. Known for their innovation in diabetes care, oncology, and immunology, Eli Lilly and Company goes toe-to-toe with Pfizer and offers robust competition.
13. Takeda Pharmaceutical Company Limited
- Product Type: Pharmaceuticals
- Industry: Pharmaceutical
- Founded Date: 1781
- Founders: Chobei Takeda I
- Headquarters: Tokyo, Japan
- Area Served: Worldwide
- Current CEO: Christophe Weber
Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. Their portfolio covers diverse areas such as gastroenterology, oncology, and neurology. Takeda’s commitment to patient-centricity and extensive R&D helps it stake a claim in the fiercely competitive pharmaceutical landscape.
14. Bayer AG
- Product Type: Pharmaceuticals, Consumer Health, Crop Science, Animal Health
- Industry: Pharmaceutical, Chemical, Agriculture
- Founded Date: August 1, 1863
- Founders: Friedrich Bayer, Johann Friedrich Weskott
- Headquarters: Leverkusen, Germany
- Area Served: Worldwide
- Current CEO: Werner Baumann
Bayer AG is a German multinational corporation known for its work in the healthcare and agriculture sectors; it produces medicines, supplements, and veterinary drugs. Their wide range of pharmaceutical products, manufacturing, marketing, and commitment to innovation make them a key competitor in the global pharmaceutical market.
15. Moderna
- Product Type: mRNA-based vaccines and therapeutics
- Industry: Biotechnology
- Founded Date: 2010
- Founders: Noubar Afeyan, Derrick Rossi, Robert Langer
- Headquarters: Cambridge, Massachusetts, United States
- Area Served: Worldwide
- Current CEO: Stéphane Bancel
Moderna is a pioneering American biotechnology company focusing on drug discovery and development based on messenger RNA (mRNA). Moderna has captured attention with data on its COVID-19 vaccine, positioning itself as a contender in the vaccine sector, including firms like Pfizer.
16. BioNTech
- Product Type: mRNA-based vaccines and therapeutics
- Industry: Biotechnology
- Founded Date: 2008
- Founders: Ugur Sahin, Özlem Türeci
- Headquarters: Mainz, Germany
- Area Served: Worldwide
- Current CEO: Ugur Sahin
BioNTech is a German biotechnology company primarily focused on developing cutting-edge cancer treatments using the body’s immune response. Its prominent position in the race to create an mRNA-based COVID-19 vaccine for cancer has helped BioNTech assert itself as a significant player in the pharmaceutical industry.
17. Novo Nordisk A/S
- Product Type: Diabetes care, Obesity care, Hemophilia care, Growth hormone therapy
- Industry: Pharmaceutical
- Founded Date: 1923
- Founders: Harald Pedersen, Thorvald Pedersen, August Krogh
- Headquarters: Bagsværd, Denmark
- Area Served: Worldwide
- Current CEO: Lars Fruergaard Jørgensen
Novo Nordisk A/S is a Danish multinational pharmaceutical company with a strong reputation as a world leader in diabetes care. They also focus on obesity, hemophilia, and growth disorders. Their specialization and commitment to improving patient outcomes make them a strong competitor to Pfizer.
18. Boehringer Ingelheim GmbH
- Product Type: Pharmaceuticals, Animal Health
- Industry: Pharmaceutical
- Founded Date: 1885
- Founders: Albert Boehringer
- Headquarters: Ingelheim am Rhein, Germany
- Area Served: Worldwide
- Current CEO: Hubertus von Baumbach
Boehringer Ingelheim GmbH is a German multinational pharmaceutical company that primarily focuses on developing drugs for respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases, and cardiovascular diseases. Their comprehensive portfolio of pharmaceutical products and commitment to healthy lives and improving health standards globally set them among key industry players.
19. Merck KGaA
- Product Type: Pharmaceuticals, Life Science, Performance Materials
- Industry: Pharmaceutical, Chemical
- Founded Date: 1668
- Founders: Friedrich Jacob Merck
- Headquarters: Darmstadt, Germany
- Area Served: Worldwide
- Current CEO: Belén Garijo
Merck KGaA is a German multinational science and technology company operating in the healthcare, life science, and performance materials sectors. It is widely known for its work in oncology and fertility treatments. Beat by beat with other multinational pharmaceutical companies, Merck KGaA’s vast offerings keep it in competition with the world’s largest pharmaceutical companies, like Pfizer.
20. Teva Pharmaceutical Industries Ltd.
- Product Type: Pharmaceuticals, Generics
- Industry: Pharmaceutical
- Founded Date: 1901
- Founders: Chaim Salomon, Moshe Levin
- Headquarters: Petah Tikva, Israel
- Area Served: Worldwide
- Current CEO: Dipankar Bhattacharjee (interim)
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company specializing in generic drugs, ingredients, and proprietary medicines. As one of the world’s biggest manufacturers of generic drugs, Teva offers considerable competition to Pfizer, especially in markets where cost-effectiveness and accessibility of prescription drugs are vital issues.
21. Biogen Inc.
- Product Type: Biotechnology, Pharmaceuticals
- Industry: Biotechnology, Pharmaceutical
- Founded Date: 1978
- Founders: Phillip Sharp, Walter Gilbert, Charles Weissmann, Heinz Schaller
- Headquarters: Cambridge, Massachusetts, United States
- Area Served: Worldwide
- Current CEO: Michel Vounatsos
Biogen Inc. is an American multinational biotechnology company specializing in discovering, developing, and delivering therapies for treating neurological diseases. The company concentrates on disease areas such as autoimmune disorders such as multiple sclerosis and hemophilia. This sets it apart from similar companies as a competitor in the pharmaceutical sector with a unique strategic focus.
22. Cipla
- Product Type: Pharmaceuticals
- Industry: Pharmaceutical
- Founded Date: 1935
- Founders: Khwaja Abdul Hamied
- Headquarters: Mumbai, India
- Area Served: Worldwide
- Current CEO: Umang Vohra
Cipla is an Indian multinational pharmaceutical company known for its affordable medicines. It produces one of the industry’s most comprehensive ranges of pharmaceutical products, spanning various sectors of healthcare products such as respiratory, urology, and cardiovascular. The company’s commitment to accessible healthcare makes it competitive in markets where cost considerations are paramount for healthcare professionals.
23. Abbott
- Product Type: Medical Devices, Pharmaceuticals, Nutrition
- Industry: Healthcare
- Founded Date: 1888
- Founders: Wallace Calvin Abbott
- Headquarters: Abbott Park, Illinois, United States
- Area Served: Worldwide
- Current CEO: Robert B. Ford
Abbott is a global healthcare company primarily focused on diagnostics, medical devices, nutritionals, and generic pharmaceuticals. Its broad portfolio and dedication to innovation make it a significant competitor in areas such as diagnostics, medical equipment and manufacturing facilities, and cardiovascular and neuromodulation products, not just pharmaceuticals.
24. Astellas Pharma Inc.
- Product Type: Pharmaceuticals
- Industry: Pharmaceutical
- Founded Date: 2005
- Headquarters: Tokyo, Japan
- Area Served: Worldwide
- Current CEO: Kenji Yasukawa
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The company focuses on therapeutic fields that include oncology, immunology, nephrology, and neurology, allowing it to hold its ground in the competitive landscape of the pharmaceutical industry.
25. Daiichi Sankyo Company, Limited
- Product Type: Pharmaceuticals
- Industry: Pharmaceutical
- Founded Date: 2005
- Headquarters: Tokyo, Japan
- Area Served: Worldwide
- Current CEO: Sunao Manabe
Daiichi Sankyo Company, Limited is a global pharmaceutical company focusing primarily on cardiovascular medicine and the frontier sectors of oncology and immune disorders. With its commitment to novel therapies in the cardiovascular and oncology drug sectors, Daiichi Sankyo Company emerges as a fierce competitor to Pfizer.
These were all the competitors of Pfizer. If you know any other competitors, please do write in the comments below.
Liked this post? Check out the complete series on Competitors
